Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Xeris Biopharma Holdings, Inc. (XERS) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$71.54M |
|
$-1.93M |
|
$11.90M |
|
$59.64M |
|
$67.06M |
|
$4.48M |
|
$-6.41M |
|
$-1.93M |
|
$-1.93M |
|
$-1.93M |
|
$-1.93M |
|
$-1.93M |
|
$-1.93M |
|
$4.48M |
|
$8.47M |
|
159.46M |
|
159.46M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$185.58M |
|
$5.28M |
|
$149.11M |
|
$334.69M |
|
$95.17M |
|
$218.63M |
|
$258.82M |
|
$353.99M |
|
$-19.30M |
|
$-135.66M |
|
$-19.30M |
|
161.22M |
|
| Cash Flow Statement Financials | |
$-9.85M |
|
$-0.29M |
|
$-2.19M |
|
$75.74M |
|
$63.41M |
|
$-12.34M |
|
$9.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.95 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
1.10 |
|
-11.33 |
|
83.37% |
|
6.27% |
|
6.27% |
|
-- |
|
-2.69% |
|
-2.69% |
|
$-10.14M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.18 |
|
1.35 |
|
66.74 |
|
9.99% |
|
1.42% |
|
-0.58% |
|
-0.97% |
|
$-0.12 |
|
$-0.06 |
|
$-0.06 |
|